Aravive
phase registrational trial design in | Aravive
Company
Deck Type
Sector
Industry
Deck date
September 2022
Slide
26 of 39
Related slides by other companies
RenovoRx
IPO
August 2021
designed for success expect one phase trial will lead to approval and commercial adoption | RenovoRx
MindMed
Investor Presentation
November 2024
key highlights of program | MindMed
Erasca
Investor Presentation
August 2023
proposed pivotal phase trial designs creative strategy includes high randomized melanoma trial and tissue agnostic indication | Erasca
RayzeBio
IPO
September 2023
phase trial in first line combination treatment of | RayzeBio
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights